Radin DP - Search Results

1

Targeting autophagy and plasminogen activator inhibitor-1 increases survival and remodels the tumor microenvironment in glioblastoma.

Shifman SG, O'Connor JL, Radin DP, Sharma A, Infante L, Ferraresso F, Kastrup CJ, Lawrence DA, Tsirka SE. Shifman SG, et al. Among authors: radin dp. J Exp Clin Cancer Res. 2025 Jul 19;44(1):214. doi: 10.1186/s13046-025-03473-w. J Exp Clin Cancer Res. 2025. PMID: 40684232 Free PMC article.

2

Lucanthone, a Potential PPT1 Inhibitor, Perturbs Stemness, Reduces Tumor Microtube Formation, and Slows the Growth of Temozolomide-Resistant Gliomas In Vivo.

Radin DP, Shifman S, Outhwaite IR, Sharma A, Bases R, Seeliger MA, Tsirka SE. Radin DP, et al. J Pharmacol Exp Ther. 2024 Mar 15;389(1):51-60. doi: 10.1124/jpet.123.002021. J Pharmacol Exp Ther. 2024. PMID: 38296645 Free PMC article.

3

Investigation of the photoluminescent properties, scintillation behaviour and toxicological profile of various magnesium tungstate nanoscale motifs.

Hurley N, Srinivas S, Fang J, Sun M, Hong S, Chien CT, Guo A, Khan TA, Li M, Cotlet M, Moretti F, Bourret E, Radin D, Tsirka SE, Shelly M, Wong SS. Hurley N, et al. R Soc Open Sci. 2022 Dec 7;9(12):220994. doi: 10.1098/rsos.220994. eCollection 2022 Dec. R Soc Open Sci. 2022. PMID: 36483754 Free PMC article.

4

Low-impact ampakine CX717 exhibits promising therapeutic profile in adults with ADHD - A phase 2A clinical trial.

Radin DP, Cerne R, Smith JL, Witkin JM, Lippa A. Radin DP, et al. Eur J Pharmacol. 2025 Oct 15;1005:178047. doi: 10.1016/j.ejphar.2025.178047. Epub 2025 Aug 7. Eur J Pharmacol. 2025. PMID: 40783159 Clinical Trial.

5

Is there a continued need for behavioral pharmacology in the discovery and development of medicines?

Witkin JM, Smith JL, Radin DP. Witkin JM, et al. Among authors: radin dp. J Pharmacol Exp Ther. 2025 May;392(5):103571. doi: 10.1016/j.jpet.2025.103571. Epub 2025 Apr 3. J Pharmacol Exp Ther. 2025. PMID: 40305918 Review.

6

Antipsychotic-like pharmacological profile of the low impact ampakine CX691 (farampator): Implications for the use of low impact ampakines in the treatment of schizophrenia.

Radin DP, Cerne R, Smith JL, Witkin JM, Lippa A. Radin DP, et al. J Psychiatr Res. 2025 Jun;186:145-153. doi: 10.1016/j.jpsychires.2025.04.019. Epub 2025 Apr 11. J Psychiatr Res. 2025. PMID: 40245529

7

AMPA Receptor Modulation in the Treatment of High-Grade Glioma: Translating Good Science into Better Outcomes.

Radin DP. Radin DP. Pharmaceuticals (Basel). 2025 Mar 8;18(3):384. doi: 10.3390/ph18030384. Pharmaceuticals (Basel). 2025. PMID: 40143160 Free PMC article. Review.

8

Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer's Disease and Ischemic Stroke.

Radin DP, Zhong S, Cerne R, Shoaib M, Smith JL, Witkin J, Lippa A. Radin DP, et al. Curr Alzheimer Res. 2024;21(10):745-754. doi: 10.2174/0115672050365821250127055828. Curr Alzheimer Res. 2024. PMID: 39931857

9

Amplification of the therapeutic potential of AMPA receptor potentiators from the nootropic era to today.

Radin DP, Lippa A, Rana S, Fuller DD, Smith JL, Cerne R, Witkin JM. Radin DP, et al. Pharmacol Biochem Behav. 2025 Mar;248:173967. doi: 10.1016/j.pbb.2025.173967. Epub 2025 Jan 31. Pharmacol Biochem Behav. 2025. PMID: 39894310 Review.

10

Safety, tolerability and pharmacokinetic profile of the low-impact ampakine CX717 in young healthy male subjects and elderly healthy male and female subjects.

Radin DP, Cerne R, Smith JL, Witkin JM, Lippa A. Radin DP, et al. Eur J Pharmacol. 2025 Apr 15;993:177317. doi: 10.1016/j.ejphar.2025.177317. Epub 2025 Jan 30. Eur J Pharmacol. 2025. PMID: 39892449 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters